Megan Martin, DPM
NPI 1760975916 · Podiatrist · Grove, OK
Enrolled with Medicare as Practitioner - Podiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1760975916
- Entity type
- Individual
- Primary specialty
- PodiatristPodiatric Medicine & Surgery Service Providers
- Credential
- DPM
- Sex
- Female
- Sole proprietor
- No
- License
- 369 (OK)
Specialties & taxonomies
Podiatric Medicine & Surgery Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
8 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,372 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Removal of Fingernails Or Toenails, 6 Or More Nails11721 | 600 | $41 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 275 | $84 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 163 | $103 |
| Removal of Skin and Tissue, 20.0 Sq Cm Or Less11042 | 76 | $111 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 49 | $155 |
| Removal of Noncancer Thickened Skin Growth, 1 Growth11055 | 46 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Gabapentin | 54 | 13 |
| Methylprednisolone | 52 | 46 |
| Terbinafine Hcl | 37 | 19 |
| Celecoxib | 21 | — |
| Ciclopirox | 19 | 12 |
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 16 | 14 |
| Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone | 11 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$160 across 10 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2018-06-12
- Last updated
- 2021-07-19
- Certified
- 2021-07-19
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.